Wed, Sep 04, 2024
Conversation with Dr Lal Pathlabs' top management on business and sector outlook. How is the current demand trend? What is the growth outlook for the future? What is the plan regarding capacity expansion? Watch Anil Singhvi's conversation with Ved Goyal, Group CFO of Dr Lal Pathlabs.
More >
Mon, May 13, 2024
Dr Lal PathLabs share price today: Diagnostics company Dr Lal PathLabs rose as much as 8.18 per cent to the day's high of Rs 2,540 on NSE in morning deals.
Fri, May 10, 2024
Dr Lal PathLabs Q4 Results: New Delhi-headquartered Dr Lal PathLabs reported a 49 per cent year-on-year jump in consolidated net profit to Rs 84.5 crore for the March quarter. Its quarterly revenue grew 11.1 per cent to Rs 545.4 crore.
Fri, May 15, 2020
Dr Arvind Lal, Advisor- FICCI Health Services Committee and Executive Chairman, Dr Lal PathLabs; Dr Narottam Puri, Advisor - FICCI Health Services Committee and Chairman - Fortis Medical Council & Fortis Healthcare Ltd; and Gautam Khanna, co-Chair -FICCI Health Services Committee and CEO, P D Hinduja Hospital & Medical Research Centre talks about COVID-19 pandemic
Fri, Mar 20, 2020
Dr Arvind Lal, Chairman and Managing Director (CMD), Dr Lal PathLabs, talks about permission granted to private path labs to test COVID-19 by Maharashtra Government, its preparedness for the same and government steps to deal with it during an interview with Swati Khandelwal, Zee Business.
Tue, Apr 26, 2016
Diagnostics company Thyrocare Technologies is set to enter the capital market on Wednesday to raise nearly Rs 480 crore. Experts see the company's valuation fairly attractive and recommends investors to subscribe to the issue for long-term.
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
